Open access
3,646
Views
29
CrossRef citations to date
0
Altmetric
Review
Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
Aline BaldoScientific Institute of Public Health (WIV-ISP), Biosafety and Biotechnology Unit, Brussels, BelgiumCorrespondence[email protected]
, Evanthia GalanisDivision of Medical Oncology, Mayo Clinic, Rochester, MN, USA
, Frédéric TangyInstitut Pasteur, Viral Genomics and Vaccination Unit, CNRS UMR3569, Paris, France
& Philippe HermanScientific Institute of Public Health (WIV-ISP), Biosafety and Biotechnology Unit, Brussels, Belgium
Pages 1102-1116
|
Received 08 Sep 2015, Accepted 14 Nov 2015, Published online: 22 Mar 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.